Live Breaking News & Updates on Daniel Salain

Stay updated with breaking news from Daniel salain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Idera Bolsters Rare Disease Portfolio with Aceragen Buyout

Two rare disease companies - Idera Pharmaceuticals and Aceragen - are merging to pursue the common goal of an FDA approval that could come as early as 2024. ....

United States , John Taylor , Carl Kraus , John Kirby , Daniel Salain , Us Defense Threat Reduction Agency , Idera Pharmaceuticals , Fast Track , Qualified Infectious Disease Product , Threat Reduction Agency , Chief Medical Officer Carl Kraus , Chief Operating Officer Daniel , General Counsel Bryant Lim , Chief Financial Officer John Kirby , Novaquest The Durham , Dera Bolsters Rare Disease Portfolio With Aceragen Buyout ,

Idera Pharma (IDRA) Acquires Aceragen

Idera Pharma (IDRA) Acquires Aceragen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , James Geraghty , Ron Wooten , Carl Kraus , Daniel Salain , Maxine Gowen , Michael Dougherty , John Taylor , Wedbush Pacgrow , Candy Jordan , Cristina Csimma , John Kirby , Farber Disease , Idera Pharmaceuticals Inc , Fenwick West , Board Of Directors For The Company , Aceragen Inc , Cystic Fibrosis Foundation , Lewis Bockius , Idera Pharmaceuticals , Novaquest Capital Management , Citizens Company , Defense Threat Reduction Agency , Wall Street , Cystic Fibrosis ,